SIOPEN

  • International Society of Paediatric Oncology Europe Neuroblastoma

Radiotherapy

 

The Radiotherapy Committee is chaired by Drs Mark Gaze, Karin Dieckmann and Tom Boterberg.

Radiotherapy involves the use of X-rays to treat cancers and is an important part of the treatment particularly of high-risk neuroblastoma. The Committee works to ensure that the radiotherapy is delivered in a standardised fashion for all patients being treated on the SIOPEN high-risk study.

SIOPEN meetings

Forthcoming meetings:

Berlin (Germany) AGM

25-27 October 2017 

click for more information

SIOPEN

SIOPEN Verein zur Foderung der Neuroblastomforschung is an Association registered in Austria and recognised as a non-profit organisation according to the Austrian Federal Tax Code (Bundesabgabenordnung BAO). Registration number ZVR 396592912. The SIOPEN Association was officially established on 20 January 2009.

This website makes use of stock photography and images do not represent particular individuals treated by SIOPEN institutions.